Oct 15 (Reuters) - Proxy advisory firm Institutional Shareholder Services on Wednesday recommended that investors in eye-care company STAAR Surgical vote against a planned deal with Alcon AG, arguing that pushback from big shareholders and other "deficiencies" speak against the proposed takeover.
STAAR's biggest investor Broadwood, which holds nearly 30% of the stock, has said it will vote against the proposal that the company will sell itself to Alcon for $28 a share. The vote is on October 23.
(Reporting by Svea Herbst-Bayliss and Maria Rugamer)
((svea.herbst@thomsonreuters.com; +617 233 2138; Reuters Messaging: svea.herbst.thomsonreuters.com@reuters.net/))